Jazz Pharmaceuticals (JAZZ)
211.97
-1.79 (0.84%)
Upcoming Events
Latest Headlines
Jazz Pharmaceuticals (JAZZ) PT Lowered to $314 at Morgan Stanley
October 21, 2026 8:22 AM - StreetInsider
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026
October 19, 2026 4:15 PM - PR NewsWire
U.S. biotech SMids: Q3 earnings preview
October 18, 2026 8:00 PM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Oct 06
October 9, 2026 9:02 AM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: ORiordan Anne
October 8, 2026 4:04 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Lowered to $296 at RBC Capital
October 8, 2026 8:27 AM - StreetInsider
Form 4 Jazz Pharmaceuticals For: Oct 06 Filed by: GALA RENEE D
October 7, 2026 5:44 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $286 at Truist Securities
October 7, 2026 7:13 AM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: GALA RENEE D
October 6, 2026 4:21 PM - SEC Filing
Entera Bio adds former Gilead executive Laura Hamill to its board
October 6, 2026 8:00 AM - StreetInsider
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
October 6, 2026 8:00 AM - StreetInsider
Form 4 Jazz Pharmaceuticals For: Oct 01 Filed by: COZADD BRUCE C
October 5, 2026 4:19 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
October 1, 2026 4:32 PM - SEC Filing
Citi initiates Jazz Pharmaceuticals coverage with Buy rating
September 30, 2026 5:01 AM - StreetInsider
Goldman Sachs Assumes Jazz Pharmaceuticals (JAZZ) at Buy
September 24, 2026 4:59 AM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Sep 23
September 23, 2026 4:15 PM - SEC Filing
UBS says this pharma name offers a robust case for stock outperformance
September 19, 2026 10:00 AM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Sep 15
September 15, 2026 9:06 AM - SEC Filing
Jazz Pharmaceuticals acquires Actio Biosciences for $820 million
September 15, 2026 9:01 AM - StreetInsider
Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences
September 15, 2026 9:00 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Sep 10 Filed by: Patil Neena M
September 14, 2026 6:38 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera
September 11, 2026 8:46 AM - StreetInsider
Form 4 Jazz Pharmaceuticals For: Sep 08 Filed by: GALA RENEE D
September 10, 2026 4:33 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Sep 08 Filed by: Henderson Mary Elizabeth
September 10, 2026 4:29 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
September 10, 2026 4:06 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $271 at Barclays
September 10, 2026 5:06 AM - StreetInsider
Canaccord Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
September 1, 2026 6:58 AM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: Iannone Robert
August 27, 2026 4:31 PM - SEC Filing
Jazz Pharmaceuticals prices $1.1B exchangeable notes offering due 2032
August 27, 2026 12:30 AM - StreetInsider
Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
August 27, 2026 12:30 AM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $277 at RBC Capital
August 26, 2026 9:00 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $322 at Morgan Stanley
August 26, 2026 8:16 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $310 at Needham
August 26, 2026 7:12 AM - StreetInsider
Jazz Pharmaceuticals plans $1B note offering and share buyback
August 26, 2026 7:00 AM - StreetInsider
Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
August 26, 2026 7:00 AM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $281 at Truist Securities
August 26, 2026 6:58 AM - StreetInsider
Canaccord Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
August 26, 2026 6:35 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $300 at Deutsche Bank
August 26, 2026 3:09 AM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Aug 25
August 25, 2026 4:07 PM - SEC Filing
FDA approves Jazz Pharmaceuticals' Ziihera for HER2+ stomach cancer
August 25, 2026 10:00 AM - StreetInsider
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
August 25, 2026 10:00 AM - PR NewsWire
Biotech funding rises 75% this year as M&A activity continues
August 17, 2026 5:16 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $283 at Morgan Stanley
August 11, 2026 9:09 AM - StreetInsider
Form 8-K Jazz Pharmaceuticals For: Aug 10
August 10, 2026 5:13 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: Aug 10
August 10, 2026 7:41 AM - SEC Filing
Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
August 10, 2026 7:30 AM - StreetInsider
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio
August 10, 2026 7:30 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Pearce Samantha
August 7, 2026 6:01 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Winningham Rick E
August 7, 2026 5:57 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: LOVE TED W
August 7, 2026 5:55 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Hamill Laura
August 7, 2026 5:51 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Kennedy Patrick
August 7, 2026 5:48 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Smith Mark Douglas
August 7, 2026 5:46 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Cook Jennifer E.
August 7, 2026 5:44 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: Mulligan Seamus
August 7, 2026 5:42 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: McSharry Heather Ann
August 7, 2026 5:39 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: ENRIGHT PATRICK G
August 7, 2026 5:37 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: RIEDEL NORBERT G
August 7, 2026 5:34 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 05 Filed by: COZADD BRUCE C
August 7, 2026 5:32 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: ORiordan Anne
August 7, 2026 2:09 PM - SEC Filing
Form SCHEDULE 13G Jazz Pharmaceuticals Filed by: FMR LLC
August 6, 2026 10:31 AM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Aug 03 Filed by: COZADD BRUCE C
August 5, 2026 4:33 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at Stifel
August 4, 2026 8:49 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $276 at JPMorgan
August 4, 2026 8:13 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $280 at Morgan Stanley
August 4, 2026 8:12 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised at TD Cowen Following 'Nice Topline Beat And Raise'
August 4, 2026 8:12 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $300 at Wells Fargo
August 4, 2026 8:06 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $292 at Needham
August 4, 2026 7:33 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $264 at Truist Securities
August 4, 2026 7:09 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $273 at RBC Capital
August 4, 2026 7:05 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised at Piper Sandler as 'Zepzelca Strength Continues'
August 4, 2026 6:55 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $280 at Baird
August 4, 2026 6:13 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $270 at Barclays
August 4, 2026 3:58 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 47c; raises guidance
August 3, 2026 4:24 PM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
August 3, 2026 4:17 PM - SEC Filing
Form 10-Q Jazz Pharmaceuticals For: Jun 30
August 3, 2026 4:09 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: Aug 03
August 3, 2026 4:07 PM - SEC Filing
Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
August 3, 2026 4:05 PM - PR NewsWire
Form 8-K Jazz Pharmaceuticals For: Jul 23
August 3, 2026 8:48 AM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: Jul 23
July 24, 2026 6:16 AM - SEC Filing
Full Article List
